Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL wins seven R&D 100 awards – total tops 100